A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder
Condition(s):Urge Incontinence; Overactive Bladder (OAB)Last Updated:April 15, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Urge Incontinence; Overactive Bladder (OAB)Last Updated:April 15, 2022Completed
Condition(s):Recurrence of Overactive Bladder SyndromeLast Updated:September 16, 2020Completed
Condition(s):Overactive BladderLast Updated:November 13, 2020Completed
Condition(s):Erectile Dysfunction; Overactive Bladder; Urinary IncontinenceLast Updated:January 5, 2021Completed
Condition(s):Overactive Bladder; Urinary IncontinenceLast Updated:April 24, 2018Completed
Condition(s):Urinary Bladder, Overactive; Sexual Behavior; Sexual Activity; Behavior Therapy; Sexual Function DisturbancesLast Updated:July 29, 2021Recruiting
Condition(s):Pharmacokinetics of Mirabegron; Food Effect; Healthy Chinese SubjectsLast Updated:November 12, 2021Completed
Condition(s):Urinary Frequency/Urgency; Bladder Irritable; Bladder Pain SyndromeLast Updated:October 22, 2020Withdrawn
Condition(s):AchalasiaLast Updated:March 24, 2021Terminated
Condition(s):Urinary Incontinence; Overactive Bladder SyndromeLast Updated:February 23, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.